{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T06:29:26Z","timestamp":1777616966707,"version":"3.51.4"},"reference-count":40,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81371841"],"award-info":[{"award-number":["81371841"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001350","name":"MOH","doi-asserted-by":"publisher","award":["WSBKTKT201402"],"award-info":[{"award-number":["WSBKTKT201402"]}],"id":[{"id":"10.13039\/501100001350","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007279","name":"Shanghai Municipal Health Bureau","doi-asserted-by":"crossref","award":["20124Y038"],"award-info":[{"award-number":["20124Y038"]}],"id":[{"id":"10.13039\/501100007279","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Vaccine"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/j.vaccine.2015.10.067","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T11:45:31Z","timestamp":1445946331000},"page":"989-994","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Partial protective immunity against toxoplasmosis in mice elicited by recombinant Toxoplasma gondii malate dehydrogenase"],"prefix":"10.1016","volume":"34","author":[{"given":"Zhuanzhuan","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fei","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanping","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Litian","family":"Yin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yisheng","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yanjuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuiyang","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Cao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.vaccine.2015.10.067_bib0205","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1017\/S0031182011001880","article-title":"Toxoplasma gondii infection in pregnant women in China","volume":"139","author":"Gao","year":"2012","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0210","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1016\/j.ijpara.2008.03.007","article-title":"Toxoplasma gondii infection in humans and animals in the United States","volume":"38","author":"Dubey","year":"2008","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0215","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1017\/S0031182012000765","article-title":"Toxoplasmosis in humans and animals in Brazil: high prevalence, high burden of disease, and epidemiology","volume":"139","author":"Dubey","year":"2012","journal-title":"Parasitology"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0220","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.ijpara.2009.02.004","article-title":"Toxoplasmosis: a history of clinical observations","volume":"39","author":"Weiss","year":"2009","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0225","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1128\/CVI.05486-11","article-title":"Anti-Toxoplasma antibody prevalence, primary infection rate, and risk factors in a study of toxoplasmosis in 4,466 pregnant women in Japan","volume":"19","author":"Sakikawa","year":"2012","journal-title":"Clin Vaccine Immunol"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0230","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00436-010-2172-8","article-title":"Transplacental transmission in cattle: is Toxoplasma gondii less potent than Neospora caninum?","volume":"108","author":"Wiengcharoen","year":"2011","journal-title":"Parasitol Res"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0235","first-page":"193","article-title":"Congenital toxoplasmosis treatment","volume":"15","author":"Serranti","year":"2011","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0240","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.clinthera.2008.10.021","article-title":"Adverse drug reactions to treatments for ocular toxoplasmosis: a retrospective chart review","volume":"30","author":"Iaccheri","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0245","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1586\/14760584.2013.844652","article-title":"Vaccines against Toxoplasma gondii: new developments and perspectives","volume":"12","author":"Zhang","year":"2013","journal-title":"Expert Rev Vac"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0250","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1462-5822.2006.00692.x","article-title":"Mucosal defences against orally acquired protozoan parasites, emphasis on Toxoplasma gondii infections","volume":"8","author":"Buzoni-Gatel","year":"2006","journal-title":"Cell Microbiol"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0255","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1128\/IAI.64.6.2158-2166.1996","article-title":"Intranasal immunization with SAG1 protein of Toxoplasma gondii in association with cholera toxin dramatically reduces development of cerebral cysts after oral infection","volume":"64","author":"Debard","year":"1996","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0260","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1007\/s13346-012-0085-z","article-title":"Strategies for intranasal delivery of vaccines","volume":"3","author":"Zaman","year":"2013","journal-title":"Drug Deliv Transl Res"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0265","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1152\/physrev.1992.72.4.853","article-title":"Molecular and cellular basis of immune protection of mucosal surfaces","volume":"72","author":"Kraehenbuhl","year":"1992","journal-title":"Physiol Rev"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0270","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/BF02786362","article-title":"Nasal lymphoid tissue, intranasal immunization, and compartmentalization of the common mucosal immune system","volume":"16","author":"Wu","year":"1997","journal-title":"Immunol Res"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0275","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1590\/S1984-29612010000400004","article-title":"Toxoplasma gondii: humoral and cellular immune response of BALB\/c mice immunized via intranasal route with rTgROP2","volume":"19","author":"Igarashi","year":"2010","journal-title":"Rev Bras Parasitol Vet"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0280","first-page":"290","article-title":"Intranasal immunization with mucosal complex vaccine protects mice against Toxoplasma gondii","volume":"25","author":"Yin","year":"2007","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0285","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.exppara.2009.01.011","article-title":"Toxoplasma gondii: proteomic analysis of antigenicity of soluble tachyzoite antigen","volume":"122","author":"Ma","year":"2009","journal-title":"Exp Parasitol"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0290","first-page":"193","article-title":"Malate dehydrogenase: distribution, function and properties","volume":"17","author":"Musrati","year":"1998","journal-title":"Gen Physiol Biophys"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0295","doi-asserted-by":"crossref","first-page":"6994","DOI":"10.1021\/jf100639n","article-title":"Kinetics of myoglobin redox form stabilization by malate dehydrogenase","volume":"58","author":"Mohan","year":"2010","journal-title":"J Agric Food Chem"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0300","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1104\/pp.110.161612","article-title":"Mitochondrial malate dehydrogenase lowers leaf respiration and alters photorespiration and plant growth in Arabidopsis","volume":"154","author":"Tomaz","year":"2010","journal-title":"Plant Physiol"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0305","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1093\/jxb\/err386","article-title":"Multiple strategies to prevent oxidative stress in Arabidopsis plants lacking the malate valve enzyme NADP-malate dehydrogenase","volume":"63","author":"Hebbelmann","year":"2012","journal-title":"J Exp Bot"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0310","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1016\/j.ijpara.2008.01.007","article-title":"Localisation of gluconeogenesis and tricarboxylic acid (TCA)-cycle enzymes and first functional analysis of the TCA cycle in Toxoplasma gondii","volume":"38","author":"Fleige","year":"2008","journal-title":"Int J Parasitol"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0315","first-page":"12","article-title":"Cloning, expression and immunogenicity analysis of malate dehydrogenase gene of Toxoplasma gondii","volume":"31","author":"Liu","year":"2013","journal-title":"Zhongguo Ji Sheng Chong Xue Yu Ji Sheng Chong Bing Za Zhi"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0320","doi-asserted-by":"crossref","first-page":"e82765","DOI":"10.1371\/journal.pone.0082765","article-title":"Intranasal immunisation with recombinant Toxoplasma gondii actin partly protects mice against toxoplasmosis","volume":"8","author":"Yin","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0325","doi-asserted-by":"crossref","first-page":"e108377","DOI":"10.1371\/journal.pone.0108377","article-title":"Partial protective effect of intranasal immunization with recombinant Toxoplasma gondii rhoptry protein 17 against toxoplasmosis in mice","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0330","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.vetpar.2013.06.013","article-title":"Evaluation of a real-time PCR assay based on the single-copy SAG1 gene for the detection of Toxoplasma gondii","volume":"197","author":"Yu","year":"2013","journal-title":"Vet Parasitol"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0335","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1111\/pim.12146","article-title":"Immunolgical response and protection of mice immunized with plasmid encoding Toxoplasma gondii glycolyticenzyme malate dehydrogenase","volume":"36","author":"Hassan","year":"2014","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0340","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1016\/j.vaccine.2006.10.060","article-title":"GRA1 protein vaccine confers better immune response compared to codon-optimized GRA1 DNA vaccine","volume":"25","author":"D\u00f6\u015fkaya","year":"2007","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0345","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1186\/1756-3305-7-431","article-title":"DNA vaccination with a gene encoding Toxoplasma gondii Deoxyribose Phosphate Aldolase (TgDPA) induces partial protective immunity against lethal challenge in mice","volume":"7","author":"Hassan","year":"2014","journal-title":"Parasit Vectors"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0350","doi-asserted-by":"crossref","first-page":"e1842","DOI":"10.1371\/journal.pntd.0001842","article-title":"Mucosal adjuvanticity of fibronectin-binding peptide (FBP) fused with Echinococcus multilocularis tetraspanin 3: systemic and local antibody responses","volume":"6","author":"Dang","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0355","doi-asserted-by":"crossref","first-page":"2629","DOI":"10.4049\/jimmunol.164.5.2629","article-title":"Decreased resistance of B cell-deficient mice to infection with Toxoplasma gondii despite unimpaired expression of IFN-gamma, TNF-alpha, and inducible nitric oxide synthase","volume":"164","author":"Kang","year":"2000","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0360","doi-asserted-by":"crossref","first-page":"800","DOI":"10.4049\/jimmunol.1100769","article-title":"Microbial infection-induced expansion of effector T cells overcomes the suppressive effects of regulatory T cells via an IL-2 deprivation mechanism","volume":"188","author":"Benson","year":"2012","journal-title":"J Immunol"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0365","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/j.1365-3024.2010.01235.x","article-title":"Circulating cytokine levels and antibody responses to human Schistosoma haematobium: IL-5 and IL-10 levels depend upon age and infection status","volume":"32","author":"Milner","year":"2010","journal-title":"Parasite Immunol"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0370","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1038\/icb.2011.93","article-title":"Insights into inflammatory bowel disease using Toxoplasma gondii as an infectious trigger","volume":"90","author":"Egan","year":"2012","journal-title":"Immunol Cell Biol"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0375","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1128\/IAI.70.9.4757-4761.2002","article-title":"Susceptibility of interleukin-2-deficient mice to Toxoplasma gondii is associated with a defect in the production of gamma interferon","volume":"70","author":"Villegas","year":"2002","journal-title":"Infect Immun"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0380","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00281-012-0339-3","article-title":"Immune response and immunopathology during toxoplasmosis","volume":"34","author":"Dupont","year":"2012","journal-title":"Semin Immunopathol"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0385","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1093\/intimm\/dxf091","article-title":"Conserved regions of protein disulfide isomerase are targeted by natural IgA antibodies in humans","volume":"14","author":"Meek","year":"2002","journal-title":"Int Immunol"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0390","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0169-409X(01)00162-4","article-title":"Nasal vaccines","volume":"51","author":"Davis","year":"2001","journal-title":"Adv Drug Deliv Rev"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0395","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/0264-410X(95)00100-F","article-title":"Specific secretory immune responses in the female genital tract following intranasal immunization with a recombinant adenovirus expressing glycoprotein B of herpes simplex virus","volume":"13","author":"Gallichan","year":"1995","journal-title":"Vaccine"},{"key":"10.1016\/j.vaccine.2015.10.067_bib0400","doi-asserted-by":"crossref","first-page":"254","DOI":"10.4049\/jimmunol.162.1.254","article-title":"Intranasal immunization with plasmid DNA\u2013lipid complexes elicits mucosal immunity in the female genital and rectal tracts","volume":"162","author":"Klavinskis","year":"1999","journal-title":"J Immunol"}],"container-title":["Vaccine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15014966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0264410X15014966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,8,15]],"date-time":"2023-08-15T16:55:05Z","timestamp":1692118505000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0264410X15014966"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2]]},"references-count":40,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S0264410X15014966"],"URL":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.067","relation":{},"ISSN":["0264-410X"],"issn-type":[{"value":"0264-410X","type":"print"}],"subject":[],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Partial protective immunity against toxoplasmosis in mice elicited by recombinant Toxoplasma gondii malate dehydrogenase","name":"articletitle","label":"Article Title"},{"value":"Vaccine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.vaccine.2015.10.067","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}